CHX TECHNOLOGIES, INC.

CHX Technologies, Inc. is a dental-focused medical device company headquartered in Shorewood, Minnesota. The company develops and commercializes Prevora, a proprietary treatment designed to address oral dysbiosis—the microbial imbalance underlying cavity and periodontal disease progression in aging populations. Prevora is positioned as a painless, evidence-based therapeutic intervention that targets the root biological causes of dental disease rather than symptomatic management alone. The company serves dental practitioners and their patients, with focus on healthy aging and preventive oral care. CHX Technologies markets Prevora to both individual patients and dental providers, offering information on clinical efficacy, reimbursement pathways, and alternative treatment venues including non-traditional dental settings. The company maintains an active research portfolio and has established partnerships through its "Partners in Prevention" initiative. Product distribution and patient access are supported through Prevolution Health, a dedicated patient engagement and support platform. While specific regulatory designations (FDA 510(k), clearance status) are not explicitly stated in available content, the positioning as a "proven" treatment suggests clinical validation. The company operates in the preventive dentistry and oral health space, targeting aging populations seeking non-invasive solutions to chronic oral disease.